More than 12% of the US population will develop a thyroid condition during their lifetime with most of these being hypothyroidism (1)
Yes, tirzepatide is more effective than semaglutide for promoting blood sugar control in type 2 diabetes and reducing body weight due to its dual action at GLP-1 and GIP receptors
Tesamorelin specifically stimulates growth hormone release, which in turn mobilizes visceral fat stores the deep abdominal fat surrounding internal organs that is most closely linked to cardiovascular disease, insulin resistance, and metabolic syndrome
Supplements arent FDA-regulated, and they can interact with medications or have side effects
But 10% had more severe side effects, and 7% stopped using it because of the discomfort
Xiao Z, Li S, Wu X, Chen X, Yan D, He J